ヨーロッパの眼科用レーザー市場
Market Size in USD Billion
CAGR :
% 
 予測期間 |
2023 –2030 |
 市場規模（基準年） |
USD 542.33 Million |
 Market Size (Forecast Year) |
USD 883.15 Million |
 CAGR |
% |
| 主要市場プレーヤー |
ヨーロッパの眼科用レーザー市場、製品別（フェムト秒レーザー、エキシマレーザー、Nd:YAG レーザー、ダイオードレーザーなど）、タイプ別（光破壊レーザー、選択的レーザー線維柱帯形成術（SLT）、光凝固レーザー）、用途別（診断および治療）、ガス別（希ガス、ハロゲンガス、バッファーガスなど）、エンドユーザー別（病院、診療所など） - 2030 年までの業界動向と予測。
ヨーロッパ眼科レーザー市場の分析と洞察
ヨーロッパの眼科用レーザー市場は、2023年から2030年の予測期間に市場成長が見込まれています。データブリッジマーケットリサーチは、市場は2023年から2030年の予測期間に6.3%のCAGRで成長し、2022年の5億4,233万米ドルから2030年には8億8,315万米ドルに達すると分析しています。
この眼科用レーザー市場レポートでは、最近の新しい開発、貿易規制、輸出入分析、生産分析、バリュー チェーンの最適化、市場シェア、国内および現地の市場プレーヤーの影響、新たな収益源の観点から見た機会の分析、市場規制の変更、戦略的市場成長分析、市場規模、カテゴリ市場の成長、アプリケーションのニッチと優位性、製品の承認、製品の発売、地理的拡張、市場における技術革新などの詳細が提供されます。眼科用レーザー市場に関する詳細情報を取得するには、アナリスト ブリーフについて Data Bridge Market Research にお問い合わせください。当社のチームは、市場の成長を達成するために情報に基づいた市場決定を行うお手伝いをします。
|
レポートメトリック |
詳細 |
|
予測期間 |
2023年から2030年 |
|
基準年 |
2022 |
|
歴史的な年 |
2021 (2015～2020年にカスタマイズ可能) |
|
定量単位 |
収益（百万米ドル） |
|
対象セグメント |
製品 (フェムト秒レーザー、エキシマレーザー、Nd:YAG レーザー、ダイオードレーザーなど)、タイプ (光破壊レーザー、選択的レーザー線維柱帯形成術 (SLT)、光凝固レーザー)、用途 (診断および治療)、ガス (希ガス、ハロゲンガス、バッファーガスなど)、エンドユーザー (病院、診療所など) |
|
対象国 |
ドイツ、フランス、イギリス、イタリア、スペイン、ロシア、トルコ、ベルギー、オランダ、スイス、その他のヨーロッパ諸国 |
|
対象となる市場プレーヤー |
ニデック株式会社、iVIS Technologies、SCHWIND eye-tech-solutions、ARC Laser GmbH、OD-OS、Quantel Medical（Lumibird Medicalの子会社）、Alcon、Ziemer Ophthalmic Systems AG、Johnson & Johnson Inc.、Bausch & Lomb Incorporated、MEDA株式会社、Topcon、Lumenis Be Ltd.、IRIDEX Corporation、Zeissなど |
市場の定義
Ophthalmology lasers are specialized medical devices that emit focused beams of light to treat various eye conditions. These lasers are commonly used in ophthalmology to perform various procedures, such as treating vision disorders, correcting refractive errors, and managing various eye diseases. The devices gained increased importance and adoption due to the high prevalence of several ophthalmic diseases, such as glaucoma, cataract, and other vision-related issues.
Europe Ophthalmology Lasers Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Increasing incidences of chronic and communicable eye diseases
The field of ophthalmology has seen a rise in the incidence of both chronic and communicable eye diseases in recent years. Some of the major factors contributing to this trend include a growing Europe population, an aging population, increased urbanization, changing lifestyles, and increased exposure to environmental pollutants. One of the most common chronic eye diseases is Age-Related Macular Degeneration (AMD). AMD is a leading cause of blindness in people over the age of 60 and is caused by damage to the macula, a small part of the retina responsible for central vision. The prevalence of AMD is expected to increase with an aging Europe population. Another chronic eye disease that is becoming more prevalent is glaucoma. Glaucoma is a group of eye diseases that cause damage to the optic nerve and can lead to blindness. It is often asymptomatic until it reaches an advanced stage, making regular eye exams crucial for early detection and treatment.
In March 2023, according to an article by Indian Express, Europe, glaucoma is the second leading cause of blindness after cataracts. It is estimated to cause blindness in 4.5 million people worldwide. Despite this, glaucoma is largely undiagnosed, with more than 90 percent of untreated cases. Thus, increasing incidences of chronic and communicable eye diseases are expected to drive the market's growth.
- Increased consumer awareness for laser treatments
Consumer awareness of laser therapies has increased, which has benefited the market for ophthalmic lasers Europe. Several factors have contributed to this trend, including advancements in technology, increased access to information, and greater emphasis on patient education. One of the main drivers of increased consumer awareness is the development of new laser systems that offer improved precision, reduced recovery times, and better outcomes. These systems have been shown to be effective in treating a range of eye conditions, from refractive errors to more complex retinal disorders. Patients are increasingly interested in these treatments and are seeking out ophthalmologists who are trained to use them. Another factor contributing to increased awareness is the availability of information about ophthalmology lasers. Patients can easily access information online about the different types of laser treatments available, their benefits, and potential risks. This has helped to demystify laser treatments and make them more accessible to a wider range of patients which is expected to drive the market's growth.
- Increasing adoption of outpatient procedures
The field of ophthalmology has seen significant advancements in recent years with the advent of laser technology. With the increasing adoption of outpatient procedures, the Europe ophthalmology lasers market presents a significant opportunity for growth. Outpatient procedures are medical procedures that do not require an overnight stay in a hospital. These procedures can be performed in a medical office, ambulatory surgery center, or outpatient clinic. Thus, the increasing adoption of outpatient procedures is expected to drive the market's growth.
Opportunities
-
Technological advancements in ophthalmology
Technological advancements in the field of ophthalmology have revolutionized the diagnosis, treatment, and management of various eye diseases and conditions. These advancements have created significant opportunities in the Europe ophthalmology lasers market, with the potential to improve patient outcomes, increase efficiency, and drive growth in the industry. One of the most significant technological advancements in ophthalmology has been the development of femtosecond lasers. These lasers are used for precision surgeries and can create incisions that are more precise and predictable than those created by traditional surgical tools. This technology has revolutionized procedures such as photocoagulation lasers, Selective Laser Trabeculoplasty (SLT), allowing for faster recovery times and better visual outcomes, which is expected to provide a lucrative opportunity for the market's growth.
Restraints/Challenges
- Lack of skilled professionals
Ophthalmology lasers are used in various procedures, including refractive surgeries, cataract surgeries, and glaucoma treatment. However, the effective use of these lasers requires skilled professionals who are proficient in handling them. The lack of such professionals can lead to errors, complications, and adverse outcomes, which can harm patients and damage the industry's reputation.
The main reason for the shortage of skilled professionals is the complexity of the equipment and the procedures involved. Ophthalmology lasers require specialized knowledge and expertise, and the training required to become proficient in using them can be time-consuming and expensive. In addition, the procedures themselves are often intricate and require a high level of skill and precision
Hence, a lack of skilled professionals will impede the growth rate of the ophthalmology lasers market. Additionally, stringent rules and regulations will further challenge the market in the forecast period.
Recent Development
- In November 2022, Alcon, the Europe leader in eye care dedicated to helping people see brilliantly, announced that it had completed its acquisition of Aerie Pharmaceuticals, Inc. This transaction helps bolster Alcon's presence in the ophthalmic pharmaceutical space with its growing portfolio of commercial products and development pipeline.
- In March 2023, Bausch + Lomb Corporation and Novaliq GmbH announced that the American Journal of Ophthalmology had published results from MOJAVE, the second pivotal Phase 3 trial for NOV03 (perfluorohexyloctane). NOV03 is being investigated to treat the signs and symptoms of Dry Eye Disease (DED) associated with Meibomian Gland Dysfunction (MGD). Results from the first pivotal Phase 3 trial, GOBI, were published earlier this year in the American Journal of Ophthalmology.
Europe Ophthalmology Lasers Market Scope
The Europe ophthalmology lasers market is segmented into product, type, application, gases, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Product
- Femtosecond Lasers
- Excimer Lasers
- Nd: YAG Lasers
- Diode Lasers
- Others
On the basis of product, the market is segmented into femtosecond lasers, excimer lasers, Nd: YAG lasers, diode lasers, and others.
Type
- Photodisruption Lasers
- Selective Laser Trabeculoplasty (SLT)
- Photocoagulation Lasers
On the basis of type, the market is segmented into photodisruption lasers, selective laser trabeculoplasty (SLT), and photocoagulation lasers.
Application
- Diagnostics
- Therapeutics
On the basis of application, the market is segmented into diagnostics and therapeutics.
Gases
- Noble gas
- Halogen gas
- Buffer gas
- Others
On the basis of gases, the market is segmented into noble gas, halogen gas, buffer gas, and others.
End User
- Hospitals
- Clinics
- Others
エンドユーザーに基づいて、市場は病院、診療所、その他に分類されます。
ヨーロッパ眼科用レーザー市場の地域分析/洞察
ヨーロッパの眼科用レーザー市場が分析され、上記のように国、製品、タイプ、用途、ガス、エンドユーザー別に市場規模の洞察と傾向が提供されます。
ヨーロッパの眼科用レーザー市場に含まれる国は、ドイツ、フランス、イギリス、イタリア、スペイン、ロシア、トルコ、ベルギー、オランダ、スイス、およびその他のヨーロッパ諸国です。
この地域では眼科疾患の有病率が高いため、ドイツがヨーロッパの眼科用レーザー市場を支配すると予想されており、急速な研究開発が市場を活性化させています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える個別の市場影響要因と市場規制の変更も提供しています。新規および交換販売、国の人口統計、疾病疫学、輸出入関税などのデータ ポイントは、個々の国の市場シナリオを予測するために使用される主要な指標の一部です。さらに、国別データの予測分析を提供する際には、ヨーロッパ ブランドの存在と可用性、地元および国内ブランドとの激しい競争により直面する課題、販売チャネルの影響が考慮されています。
競争環境と欧州眼科用レーザー市場シェア分析
ヨーロッパ眼科用レーザー市場の競争状況は、競合他社による詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、ヨーロッパでのプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータ ポイントは、ヨーロッパ眼科用レーザー市場における会社の焦点にのみ関連しています。
ヨーロッパの眼科用レーザー市場で事業を展開している主要企業としては、NIDEK CO., LTD.、iVIS Technologies、SCHWIND eye-tech-solutions、ARC Laser GmbH、OD-OS、Quantel Medical（Lumibird Medicalの子会社）、Alcon、Ziemer Ophthalmic Systems AG、Johnson & Johnson Inc.、Bausch & Lomb Incorporated、MEDA Co., Ltd.、Topcon、Lumenis Be Ltd.、IRIDEX Corporation、Zeissなどが挙げられます。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE OPHTHALMOLOGY LASERS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 EUROPE OPHTHALMOLOGY LASERS MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 STRATEGIC INITIATIVES
5 EUROPE OPHTHALMOLOGY LASERS MARKET, REGULATION
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING INCIDENCES OF CHRONIC AND COMMUNICABLE EYE DISEASES
6.1.2 INCREASED CONSUMER AWARENESS FOR LASER TREATMENTS
6.1.3 INCREASING ADOPTION OF OUTPATIENT PROCEDURES
6.1.4 RISING DEMAND FOR MINIMALLY INVASIVE SURGICAL PROCEDURES
6.2 RESTRAINTS
6.2.1 HIGH COST OF OPHTHALMOLOGY LASER PROCEDURES
6.2.2 STRINGENT REGULATORY POLICIES
6.3 OPPORTUNITIES
6.3.1 TECHNOLOGICAL ADVANCEMENTS IN OPHTHALMOLOGY
6.3.2 EMERGING MARKETS AND GOVERNMENT FUNDING
6.4 CHALLENGES
6.4.1 LACK OF SKILLED PROFESSIONALS
6.4.2 SAFETY CONCERNS
7 EUROPE OPHTHALMOLOGY LASERS MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 EXCIMER LASERS
7.2.1 ARF
7.2.2 KRF
7.2.3 XECL
7.2.4 XEFL
7.2.5 F2
7.2.6 XEBR
7.3 FEMTOSECOND LASERS
7.3.1 SEMICONDUCTOR LASERS
7.3.2 SOLID-STATE BULK LASERS
7.3.3 FREQUENCY-CONVERTED SOURCES
7.3.4 FIBER LASERS
7.3.5 DYE LASERS
7.3.6 OTHERS
7.4 ND:YAG LASERS
7.4.1 ND: YAG LASER AT 1064 NM
7.4.2 ND: YAG GREEN LASER AT 532 NM
7.5 DIODE LASERS
7.6 OTHERS
8 EUROPE OPHTHALMOLOGY LASERS MARKET, BY TYPE
8.1 OVERVIEW
8.2 PHOTOCOAGULATION LASERS
8.3 SELECTIVE LASER TRABECULOPLASTY (SLT)
8.4 PHOTODISRUPTION LASERS
9 EUROPE OPHTHALMOLOGY LASERS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 THERAPEUTICS
9.2.1 CATARACT REMOVAL
9.2.2 GLAUCOMA TREATMENT
9.2.3 DIABETIC RETINOPATHY TREATMENT
9.2.4 REFRACTIVE ERROR CORRECTION
9.2.5 AMD TREATMENT
9.2.6 OTHERS
9.3 DIAGNOSTICS
9.3.1 OPTICAL COHERENCE TOMOGRAPHY (OCT)
9.3.2 SCANNING LASER OPHTHALMOSCOPE (SLO)
10 EUROPE OPHTHALMOLOGY LASERS MARKET, BY GASES
10.1 OVERVIEW
10.2 NOBLE GAS
10.2.1 ARGON
10.2.2 XENON
10.2.3 KRYPTON
10.3 HALOGEN GAS
10.3.1 CHLORINE
10.3.2 BROMINE
10.3.3 FLOURINE
10.4 BUFFER GAS
10.4.1 HELIUM
10.4.2 NEON
10.5 OTHERS
11 EUROPE OPHTHALMOLOGY LASERS MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 CLINICS
11.4 OTHERS
12 EUROPE OPHTHALMOLOGY LASERS MARKET, BY REGION
12.1 EUROPE
12.1.1 GERMANY
12.1.2 FRANCE
12.1.3 U.K.
12.1.4 ITALY
12.1.5 SPAIN
12.1.6 RUSSIA
12.1.7 TURKEY
12.1.8 BELGIUM
12.1.9 NETHERLANDS
12.1.10 SWITZERLAND
12.1.11 REST OF EUROPE
13 EUROPE OPHTHALMOLOGY LASERS MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 EUROPE OPHTHALMOLOGY LASERS MARKET, CPS
15.1 BAUSCH & LOMB INCORPORATED
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 JOHNSON & JOHNSON, INC.
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 ZEISS
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 ALCON
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 NIDEK CO., LTD
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 ARC LASER GMBH
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENT
15.7 AUROLAB
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 CALMAR LASER
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 IRIDEX CORPORATION
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENT
15.1 IVIS TECHNOLOGIES
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 LENSAR, INC.
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 LUMENIS BE LTD.
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 LIGHTMED
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 MEDA CO., LTD.
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 OD-OS
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 QUANTEL MEDICAL (A SUBSIDIARY OF LUMIBIRD MEDICAL)
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENT
15.17 SCHWIND EYE-TECH-SOLUTIONS
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 TOPCON
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENT
15.19 ZIEMER OPHTHALMIC SYSTEMS AG
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
表のリスト
TABLE 1 EUROPE OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 2 EUROPE OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 3 EUROPE EXCIMER LASERS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 EUROPE EXCIMER LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 5 EUROPE FEMTOSECOND LASERS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 EUROPE FEMTOSECOND LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 7 EUROPE ND:YAG LASERS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 EUROPE ND:YAG LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 9 EUROPE DIODE LASERS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 EUROPE OTHERS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 EUROPE OPHTHALMOLOGY LASERS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 12 EUROPE PHOTOCOAGULATION LASERS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 EUROPE SELECTIVE LASER TRABECULOPLASTY (SLT) IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 EUROPE PHOTODISRUPTION LASERS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 EUROPE OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 16 EUROPE THERAPEUTICS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 EUROPE THERAPEUTICS IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 18 EUROPE DIAGNOSTICS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 EUROPE DIAGNOSTIC IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 20 EUROPE OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 21 EUROPE NOBLE GAS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 EUROPE NOBLE GASES IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 23 EUROPE HALOGEN GAS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 EUROPE HALOGEN GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 25 EUROPE BUFFER GAS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 EUROPE BUFFER GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 27 EUROPE OTHERS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 EUROPE OPHTHALMOLOGY LASERS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 29 EUROPE HOSPITALS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 EUROPE CLINICS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 EUROPE OTHERS IN OPHTHALMOLOGY LASERS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 EUROPE OPHTHALMOLOGY LASERS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 33 EUROPE OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 34 EUROPE OPHTHALMOLOGY LASERS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 35 EUROPE EXCIMER LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 36 EUROPE FEMTOSECOND LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 37 EUROPE ND:YAG LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 38 EUROPE OPHTHALMOLOGY LASERS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 39 EUROPE OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 40 EUROPE THERAPEUTICS IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 41 EUROPE DIAGNOSTIC IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 42 EUROPE OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 43 EUROPE NOBLE GASES IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 44 EUROPE HALOGEN GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 45 EUROPE BUFFER GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 46 EUROPE OPHTHALMOLOGY LASERS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 47 GERMANY OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 48 GERMANY OPHTHALMOLOGY LASERS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 49 GERMANY OPHTHALMOLOGY LASERS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 50 GERMANY EXCIMER LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 51 GERMANY FEMTOSECOND LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 52 GERMANY ND:YAG LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 53 GERMANY OPHTHALMOLOGY LASERS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 54 GERMANY OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 55 GERMANY THERAPEUTICS IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 56 GERMANY DIAGNOSTIC IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 57 GERMANY OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 58 GERMANY NOBLE GASES IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 59 GERMANY HALOGEN GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 60 GERMANY BUFFER GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 61 GERMANY OPHTHALMOLOGY LASERS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 62 FRANCE OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 FRANCE OPHTHALMOLOGY LASERS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 64 FRANCE OPHTHALMOLOGY LASERS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 65 FRANCE EXCIMER LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 66 FRANCE FEMTOSECOND LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 67 FRANCE ND:YAG LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 68 FRANCE OPHTHALMOLOGY LASERS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 69 FRANCE OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 70 FRANCE THERAPEUTICS IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 71 FRANCE DIAGNOSTIC IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 FRANCE OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 73 FRANCE NOBLE GASES IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 74 FRANCE HALOGEN GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 75 FRANCE BUFFER GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 76 FRANCE OPHTHALMOLOGY LASERS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 77 U.K. OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 78 U.K. OPHTHALMOLOGY LASERS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 79 U.K. OPHTHALMOLOGY LASERS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 80 U.K. EXCIMER LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 81 U.K. FEMTOSECOND LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 82 U.K. ND:YAG LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 83 U.K. OPHTHALMOLOGY LASERS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 84 U.K. OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 85 U.K. THERAPEUTICS IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 86 U.K. DIAGNOSTIC IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 87 U.K. OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 88 U.K. NOBLE GASES IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 89 U.K. HALOGEN GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 90 U.K. BUFFER GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 91 U.K. OPHTHALMOLOGY LASERS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 92 ITALY OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 93 ITALY OPHTHALMOLOGY LASERS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 94 ITALY OPHTHALMOLOGY LASERS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 95 ITALY EXCIMER LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 96 ITALY FEMTOSECOND LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 97 ITALY ND:YAG LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 98 ITALY OPHTHALMOLOGY LASERS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 99 ITALY OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 100 ITALY THERAPEUTICS IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 101 ITALY DIAGNOSTIC IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 102 ITALY OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 103 ITALY NOBLE GASES IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 104 ITALY HALOGEN GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 105 ITALY BUFFER GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 106 ITALY OPHTHALMOLOGY LASERS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 107 SPAIN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 108 SPAIN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 109 SPAIN OPHTHALMOLOGY LASERS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 110 SPAIN EXCIMER LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 111 SPAIN FEMTOSECOND LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 112 SPAIN ND:YAG LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 113 SPAIN OPHTHALMOLOGY LASERS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 114 SPAIN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 115 SPAIN THERAPEUTICS IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 116 SPAIN DIAGNOSTIC IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 117 SPAIN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 118 SPAIN NOBLE GASES IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 119 SPAIN HALOGEN GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 120 SPAIN BUFFER GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 121 SPAIN OPHTHALMOLOGY LASERS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 122 RUSSIA OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 123 RUSSIA OPHTHALMOLOGY LASERS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 124 RUSSIA OPHTHALMOLOGY LASERS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 125 RUSSIA EXCIMER LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 126 RUSSIA FEMTOSECOND LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 127 RUSSIA ND:YAG LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 128 RUSSIA OPHTHALMOLOGY LASERS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 RUSSIA OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 130 RUSSIA THERAPEUTICS IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 131 RUSSIA DIAGNOSTIC IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 132 RUSSIA OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 133 RUSSIA NOBLE GASES IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 134 RUSSIA HALOGEN GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 135 RUSSIA BUFFER GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 136 RUSSIA OPHTHALMOLOGY LASERS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 137 TURKEY OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 138 TURKEY OPHTHALMOLOGY LASERS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 139 TURKEY OPHTHALMOLOGY LASERS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 140 TURKEY EXCIMER LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 141 TURKEY FEMTOSECOND LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 142 TURKEY ND:YAG LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 143 TURKEY OPHTHALMOLOGY LASERS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 144 TURKEY OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 145 TURKEY THERAPEUTICS IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 146 TURKEY DIAGNOSTIC IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 147 TURKEY OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 148 TURKEY NOBLE GASES IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 149 TURKEY HALOGEN GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 150 TURKEY BUFFER GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 151 TURKEY OPHTHALMOLOGY LASERS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 152 BELGIUM OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 153 BELGIUM OPHTHALMOLOGY LASERS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 154 BELGIUM OPHTHALMOLOGY LASERS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 155 BELGIUM EXCIMER LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 156 BELGIUM FEMTOSECOND LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 157 BELGIUM ND:YAG LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 158 BELGIUM OPHTHALMOLOGY LASERS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 159 BELGIUM OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 160 BELGIUM THERAPEUTICS IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 161 BELGIUM DIAGNOSTIC IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 162 BELGIUM OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 163 BELGIUM NOBLE GASES IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 164 BELGIUM HALOGEN GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 165 BELGIUM BUFFER GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 166 BELGIUM OPHTHALMOLOGY LASERS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 167 NETHERLANDS OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 168 NETHERLANDS OPHTHALMOLOGY LASERS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 169 NETHERLANDS OPHTHALMOLOGY LASERS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 170 NETHERLANDS EXCIMER LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 171 NETHERLANDS FEMTOSECOND LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 172 NETHERLANDS ND:YAG LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 173 NETHERLANDS OPHTHALMOLOGY LASERS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 174 NETHERLANDS OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 175 NETHERLANDS THERAPEUTICS IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 176 NETHERLANDS DIAGNOSTIC IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 177 NETHERLANDS OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 178 NETHERLANDS NOBLE GASES IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 179 NETHERLANDS HALOGEN GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 180 NETHERLANDS BUFFER GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 181 NETHERLANDS OPHTHALMOLOGY LASERS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 182 SWITZERLAND OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 183 SWITZERLAND OPHTHALMOLOGY LASERS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 184 SWITZERLAND OPHTHALMOLOGY LASERS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 185 SWITZERLAND EXCIMER LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 186 SWITZERLAND FEMTOSECOND LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 187 SWITZERLAND ND:YAG LASERS IN OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 188 SWITZERLAND OPHTHALMOLOGY LASERS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 189 SWITZERLAND OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 190 SWITZERLAND THERAPEUTICS IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 191 SWITZERLAND DIAGNOSTIC IN OPHTHALMOLOGY LASERS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 192 SWITZERLAND OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 193 SWITZERLAND NOBLE GASES IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 194 SWITZERLAND HALOGEN GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 195 SWITZERLAND BUFFER GAS IN OPHTHALMOLOGY LASERS MARKET, BY GASES, 2021-2030 (USD MILLION)
TABLE 196 SWITZERLAND OPHTHALMOLOGY LASERS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 197 REST OF EUROPE OPHTHALMOLOGY LASERS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 198 REST OF EUROPE OPHTHALMOLOGY LASERS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 199 REST OF EUROPE OPHTHALMOLOGY LASERS MARKET, BY PRODUCTS, 2021-2030, (ASP)
図表一覧
FIGURE 1 EUROPE OPHTHALMOLOGY LASERS MARKET: SEGMENTATION
FIGURE 2 EUROPE OPHTHALMOLOGY LASERS MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE OPHTHALMOLOGY LASERS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE OPHTHALMOLOGY LASERS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE OPHTHALMOLOGY LASERS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE OPHTHALMOLOGY LASERS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE OPHTHALMOLOGY LASERS MARKET: DBMR POSITION GRID
FIGURE 8 EUROPE OPHTHALMOLOGY LASERS MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 EUROPE OPHTHALMOLOGY LASERS MARKET: END USER COVERAGE GRID
FIGURE 10 EUROPE OPHTHALMOLOGY LASERS MARKET: SEGMENTATION
FIGURE 11 RISING TRAUMATIC INJURIES AND AN INCREASING GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE EUROPE OPHTHALMOLOGY LASERS MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 EXCIMER LASERS IS EXPECTED TO HAVE THE LARGEST SHARE OF THE EUROPE OPHTHALMOLOGY LASERS MARKET IN THE FORECAST PERIOD 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE OPHTHALMOLOGY LASERS MARKET
FIGURE 14 EUROPE OPHTHALMOLOGY LASERS MARKET: BY PRODUCT, 2022
FIGURE 15 EUROPE OPHTHALMOLOGY LASERS MARKET: BY PRODUCT 2023-2030 (USD MILLION)
FIGURE 16 EUROPE OPHTHALMOLOGY LASERS MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 EUROPE OPHTHALMOLOGY LASERS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 EUROPE OPHTHALMOLOGY LASERS MARKET: BY TYPE, 2022
FIGURE 19 EUROPE OPHTHALMOLOGY LASERS MARKET: BY TYPE 2023-2030 (USD MILLION)
FIGURE 20 EUROPE OPHTHALMOLOGY LASERS MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 21 EUROPE OPHTHALMOLOGY LASERS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 EUROPE OPHTHALMOLOGY LASERS MARKET: BY APPLICATION, 2022
FIGURE 23 EUROPE OPHTHALMOLOGY LASERS MARKET: BY APPLICATION 2023-2030 (USD MILLION)
FIGURE 24 EUROPE OPHTHALMOLOGY LASERS MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 EUROPE OPHTHALMOLOGY LASERS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 EUROPE OPHTHALMOLOGY LASERS MARKET: BY GASES, 2022
FIGURE 27 EUROPE OPHTHALMOLOGY LASERS MARKET: BY GASES 2023-2030 (USD MILLION)
FIGURE 28 EUROPE OPHTHALMOLOGY LASERS MARKET: BY GASES, CAGR (2023-2030)
FIGURE 29 EUROPE OPHTHALMOLOGY LASERS MARKET: BY GASES, LIFELINE CURVE
FIGURE 30 EUROPE OPHTHALMOLOGY LASERS MARKET: BY END USER, 2022
FIGURE 31 EUROPE OPHTHALMOLOGY LASERS MARKET: BY END USER 2023-2030 (USD MILLION)
FIGURE 32 EUROPE OPHTHALMOLOGY LASERS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 33 EUROPE OPHTHALMOLOGY LASERS MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 EUROPE OPHTHALMOLOGY LASERS MARKET: SNAPSHOT (2022)
FIGURE 35 EUROPE OPHTHALMOLOGY LASERS MARKET: BY COUNTRY (2022)
FIGURE 36 EUROPE OPHTHALMOLOGY LASERS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 EUROPE OPHTHALMOLOGY LASERS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 EUROPE OPHTHALMOLOGY LASERS MARKET: BY PRODUCT (2023-2030)
FIGURE 39 EUROPE OPHTHALMOLOGY LASERS MARKET: COMPANY SHARE 2022 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
